Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
Phospho-Bcl-2 (Ser70) (5H2) Rabbit mAb 2827 40 µl
Western Blotting Immunofluorescence Flow Cytometry
H 28 Rabbit IgG
Phospho-Bcl-2 (Thr56) Antibody (Human Specific) 2875 40 µl
Western Blotting
H 28 Rabbit 
Bcl-2 (50E3) Rabbit mAb 2870 40 µl
Western Blotting Immunoprecipitation
H M R 26 Rabbit 
Bcl-xL (54H6) Rabbit mAb 2764 40 µl
Western Blotting Immunoprecipitation Immunohistochemistry Immunofluorescence Flow Cytometry
H M R Mk 30 Rabbit IgG
Mcl-1 (D35A5) Rabbit mAb 5453 40 µl
Western Blotting
H M Mk 40 (human), 35 (mouse) Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
Western Blotting
All Goat 

Product Description

The Pro-Survival Bcl-2 Family Antibody Sampler Kit provides an economical means to examine several members of the Bcl-2 family. The kit contains enough primary and secondary antibodies to perform four western blot experiments.


Specificity / Sensitivity

Each antibody in the Pro-Survival Bcl-2 Family Antibody Sampler Kit recognizes only its specific target. The antibodies do not cross-react with other Bcl-2 family members. Phospho-Bcl-2 (Ser70) (5H2) Rabbit mAb detects endogenous levels of human Bcl-2 only when phosphorylated at Ser70. Phospho-Bcl-2 (Thr56) Antibody (Human Specific) detects endogenous levels of human Bcl-2 only when phosphorylated at Thr56.


Source / Purification

Total Mcl-1, Bcl-xL, and Bcl-2 monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Leu210 of human Mcl-1, Asp61 of human Bcl-xL, and residues at the carboxy terminus of human Bcl-2 alpha. Phospho-Bcl-2 (Ser70) (5H2) Rabbit mAb is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser70 of human Bcl-2. Phospho-Bcl-2 (Thr56) Antibody (Human Specific) is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr56 of human Bcl-2. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.

The Bcl-2 family consists of a number of evolutionarily conserved proteins containing Bcl-2 homology domains (BH) that regulate apoptosis through control of mitochondrial membrane permeability and release of cytochrome c (1-3). Four BH domains have been identified (BH1-4) that mediate protein interactions. The family can be separated into three groups based upon function and sequence homology: pro-survival members include Bcl-2, Bcl-xL, Mcl-1, A1 and Bcl-w; pro-apoptotic proteins include Bax, Bak and Bok, and "BH3 only" proteins Bad, Bik, Bid, Puma, Bim, Bmf, Noxa and Hrk. Interactions between death-promoting and death-suppressing Bcl-2 family members has led to a rheostat model in which the ratio of pro-apoptotic and anti-apoptotic proteins controls cell fate (4). Thus, pro-survival members exert their behavior by binding to and antagonizing death-promoting members. In general, the "BH3-only members" can bind to and antagonize the pro-survival proteins leading to increased apoptosis (5). While some redundancy of this system likely exists, tissue specificity, transcriptional and post-translational regulation of many of these family members can account for distinct physiological roles.


Several phosphorylation sites have been identified within Bcl-2 including Thr56, Ser70, Thr74 and Ser87 (6). These phosphorylation sites may be targets of the ASK1/MKK7/JNK1 pathway, and phosphorylation of Bcl-2 may be a marker for mitotic events (7,8). Mutation of Bcl-2 at Thr56 or Ser87 inhibits its anti-apoptotic activity during glucocorticoid-induced apoptosis of T lymphocytes (9). Interleukin 3 and JNK-induced Bcl-2 phosphorylation at Ser70 may be required for its enhanced antiapoptotic functions (10).


1.  Cory, S. et al. (2003) Oncogene 22, 8590-607.

2.  Antonsson, B. and Martinou, J.C. (2000) Exp Cell Res 256, 50-7.

3.  Sharpe, J.C. et al. (2004) Biochim Biophys Acta 1644, 107-13.

4.  Korsmeyer, S.J. et al. (1993) Semin Cancer Biol 4, 327-32.

5.  Bouillet, P. and Strasser, A. (2002) J Cell Sci 115, 1567-74.

6.  Maundrell, K. et al. (1997) J. Biol. Chem. 272, 25238-25242.

7.  Yamamoto, K. et al. (1999) Mol. Cell Biol. 19, 8469-8478.

8.  Ling, Y. H. et al. (1998) J. Biol. Chem. 273, 18984-18991.

9.  Huang, S.J. and Cidlowski, J.A. (2002) FASEB 16, 825-832.

10.  Deng, X. et al. (2001) J. Biol. Chem. 276, 23681-23688.


Entrez-Gene Id 598, 596, 4170
Swiss-Prot Acc. Q07817, P10415, Q07820


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
U.S. Patent No. 5,675,063.